Cargando…
Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1
The oral S1PR1 agonist ponesimod demonstrated substantial efficacy in a phase II clinical trial of psoriasis. Unfortunately, systemic side effects were observed, which included lymphopenia and transient bradycardia. We sought to develop a topical soft-drug S1PR1 agonist with an improved therapeutic...
Autores principales: | Bell, Mark, Foley, David, Naylor, Claire, Robinson, Colin, Riley, Jennifer, Epemolu, Ola, Scullion, Paul, Shishikura, Yoko, Katz, Elad, McLean, W.H. Irwin, Wyatt, Paul, Read, Kevin D., Woodland, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185871/ https://www.ncbi.nlm.nih.gov/pubmed/30143424 http://dx.doi.org/10.1016/j.bmcl.2018.07.044 |
Ejemplares similares
-
Discovery of Soft-Drug Topical Tool Modulators of
Sphingosine-1-phosphate Receptor 1 (S1PR1)
por: Bell, Mark, et al.
Publicado: (2019) -
The Ying and Yang of Sphingosine-1-Phosphate Signalling within the Bone
por: Frost, Kathryn, et al.
Publicado: (2023) -
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021) -
Identification
of Morpholino Thiophenes as
Novel Mycobacterium tuberculosis Inhibitors, Targeting
QcrB
por: Cleghorn, Laura A. T., et al.
Publicado: (2018) -
Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)